The most common gene mutations in cutaneous melanoma affect the activity of the mitogen-activated protein kinase (MAPK) signaling pathway, which is one of the main regulators of cell proliferation, differentiation and survival [5,28,29]. Here, WNK2 is linked to cutaneous melanoma.